Archive - March 2018
Opioid overdose ER cases rise 30%, according to CDC
Bristol-Myers Squibb looks for Opdivo convenience edge with new 4-week dosing
Themis nabs CEPI’s first grant of $37.5M to develop Lassa and MERS vaccines
Hospira issues voluntary recall of hydromorphone due to possible cracked vials
Gilead says switching studies back new HIV therapy Biktarvy
Dermira craters as acne drug fails late-stage test
Superbugs & Superdrugs Conference 2018
Verma: Meaningful-use overhaul is coming